SecBot SecBot
8-K ·Filed May 22, 2026

COSM

Cosmos Health Inc.
MIXED
Impact 5/10
Horizonweeks Processed5mo ago SEC0001477932-26-003403
8-K Item 2.02: Earnings release
Actionable Insight ◆ Mixed

Revenue growth is strong (+31% YoY) but GAAP profitability deteriorated and the S-3 shelf filed 28 days ago creates significant dilution risk. Monitor for any equity issuance under the shelf and watch for Q2 2026 results to see if Adjusted EBITDA turns positive as guided. The stock's $13M market cap makes it highly sensitive to any news flow around the shelf or U.S. expansion execution.

DirectionMixed
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
COSM ▼ -18.34% at T+60d
NEUTRAL call -18.34% · α vs SPY -21.53% · entry $0.2530 → $0.2066
Entry = T+0 close
May 22, 2026
via day close
T+1d
+3.95%
call +3.95% · α +3.37%
$0.2630
settled 5mo ago
T+5d
-0.16%
call -0.16% · α -1.83%
$0.2526
settled 5mo ago
T+20d
-23.91%
call -23.91% · α -22.50%
$0.1925
settled 4mo ago
T+60d
-18.34%
call -18.34% · α -21.53%
$0.2066
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Cosmos Health reported Q1 2026 revenue of $17.93M, up 30.7% YoY, a new Q1 record, but GAAP net loss widened to ($2.81M) from ($0.82M) in Q1 2025, driven by non-cash items including digital asset mark-to-market losses and non-cash interest. The company reduced total liabilities by $4.5M (9.6%) and increased stockholders' equity by 7.6%, while Adjusted EBITDA was near breakeven at ($229,596). No formal guidance was provided, and the company continues to face a dilutive S-3 shelf registration filed 28 days prior, creating significant overhang.

Key Financial Metrics

EPS
−$0.02
est −$0.01 · -100.0%
Revenue
$17.9M
est $23.8M · -24.7% · +30.7% YoY
Rating
miss
Gross Margin
7.7%

Key Facts

  • Q1 2026 revenue of $17.93M, up 30.7% from $13.71M in Q1 2025
  • GAAP net loss widened to ($2.81M) from ($0.82M) in Q1 2025
  • Adjusted EBITDA near breakeven at ($229,596) vs positive $373,119 in Q1 2025
  • Total liabilities reduced by $4.51M (9.6%) to $42.54M
  • Stockholders' equity increased by $1.40M (7.6%) to $19.83M
  • Cash and cash equivalents of $2.16M, down from $3.46M at year-end 2025
  • Gross profit declined to $1.38M from $2.05M, reflecting mix shift toward wholesale distribution
  • S-3 shelf registration filed April 24, 2026 enables 73.5M share resale by selling stockholders
  • No formal guidance provided; management cites 'record momentum' into Q2

Financial Impact

Revenue beat consensus of $23.8M by -24.7% (actual $17.93M); GAAP EPS miss of -29.2% vs consensus ($-0.31 actual vs $-0.24 est). Net loss widened by $1.99M YoY.

revenueepsgrossProfitcashFlowdebt

Risk Factors

  • Dilution risk from S-3 shelf registration enabling 73.5M share resale
  • Widening GAAP net loss and negative operating cash flow
  • Declining gross margin due to revenue mix shift toward wholesale
  • Digital asset volatility (Ethereum holdings) impacting earnings
  • Going concern doubts previously raised in FY2025 filing
  • Low cash balance ($2.16M) relative to operating losses

Market Snapshot

Exchange
Nasdaq
Sector
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001477932-26-003403
Document: cosm_8k.htm0001477932-26-003403
Document: 0001477932-26-003403-index-headers.html0001477932-26-003403
Document: 0001477932-26-003403-index.html0001477932-26-003403
Document: 0001477932-26-003403.txt0001477932-26-003403
8-K Data (Synthetic)0001477932-26-003403
33 reports for COSM
Performance horizon
50% Hit rate @ T+20 3 of 6 directional calls Went positive at some point 7 of 8 best @ T+60▲ +66.26%Jul 20, 2026
Filters
Rows
Reports for COSM — sortable, filterable
TypeNow
Oct 22, 2026
4d ago
8-K
BULLISH ★ 6/10
$0.2530awaiting T+20—$0.2610 (+3.16%)
Oct 16, 2026
10d ago
SC 13G/A
NEUTRAL ★ 3/10
$0.3250awaiting T+20—$0.2610 (−19.69%)
Oct 9, 2026
17d ago
8-K
NEUTRAL ★ 4/10
$0.3496awaiting T+20—$0.2610 (−25.34%)
Sep 3, 2026
7w ago
Press Release
BEARISH ★ 6/10
$0.2660 $0.4300▼ −61.65%▼ −62.77%$0.2610 (+1.88%)
Aug 19, 2026
9w ago
Press Release
BEARISH ★ 6/10
$0.1930awaiting T+20—$0.2610 (−35.23%)
Jul 20, 2026
14w ago
Press Release
BULLISH ★ 4/10
$0.2303 $0.2050▼ −10.99%▼ −15.11%$0.2610 (+13.33%)
Jul 17, 2026
14w ago
Press Release
NEUTRAL ★ 3/10
$0.2348 $0.2179▼ −7.20%▼ −11.64%$0.2610 (+11.16%)
Jul 16, 2026
14w ago
Press Release
NEUTRAL ★ 3/10
$0.2807 $0.2065▼ −26.43%▼ −30.05%$0.2610 (−7.02%)
Jul 15, 2026
14w ago
Press Release
NEUTRAL ★ 3/10
$0.2785 $0.2071▼ −25.64%▼ −27.98%$0.2610 (−6.28%)
Jul 14, 2026
14w ago
Press Release
NEUTRAL ★ 3/10
$0.3071 $0.2198▼ −28.43%▼ −30.92%$0.2610 (−15.01%)
Showing 10 of 33

US Market Status

Market Closed — Opens Wed (12h 36m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 22, 2026